Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hepatitis C
100%
Machine Learning Prediction
100%
Direct-acting Antiviral Therapy
100%
Duration of Therapy
100%
Direct-acting Antiviral Treatment
100%
Direct-acting Antivirals
75%
Quality of Life
50%
Machine Learning Models
50%
Patient Characteristics
50%
Decompensated Cirrhosis
50%
United States
25%
Treatment Duration
25%
Area under the Receiver Operating Characteristic Curve
25%
Predictive Models
25%
Type 2 Diabetes Mellitus (T2DM)
25%
Comorbidity
25%
XGBoost
25%
Extended Treatment
25%
Claims Data
25%
Prolonged Treatment
25%
Lifetime Enhancement
25%
Sofosbuvir
25%
Managed Care
25%
Antiviral Resistance
25%
Comorbidity Burden
25%
Ledipasvir
25%
Prolonged Course
25%
Chronic Infection
25%
Blood-borne Pathogens
25%
Multiple Comorbidities
25%
Care Plan
25%
Diabetes Status
25%
Medicine and Dentistry
Hepatitis C
100%
Antiviral Therapy
100%
Treatment Duration
100%
Antivirus Agent
37%
Comorbidity
37%
Quality of Life
25%
Patient Characteristics
25%
Health Care Cost
12%
Infection
12%
Pathogen
12%
Maturity Onset Diabetes of the Young
12%
Retrospective Study
12%
Ledipasvir Plus Sofosbuvir
12%
Decompensated Liver Cirrhosis
12%
Liver Cirrhosis
12%
Antiviral Resistance
12%
Nursing and Health Professions
Hepatitis C
100%
Treatment Duration
100%
Antiviral Therapy
100%
Antivirus Agent
50%
Comorbidity
37%
Quality of Life
25%
Area under the Curve
25%
Infection
12%
Receiver Operating Characteristic
12%
Practice Guideline
12%
Non Insulin Dependent Diabetes Mellitus
12%
Decompensated Liver Cirrhosis
12%
Ledipasvir Plus Sofosbuvir
12%
Liver Cirrhosis
12%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
100%
Antiviral Therapy
100%
Hepatitis C
100%
Comorbidity
37%
Infection
12%
Liver Cirrhosis
12%
Retrospective Study
12%
Ledipasvir Plus Sofosbuvir
12%
Bloodborne Bacterium
12%
Decompensated Liver Cirrhosis
12%
Non Insulin Dependent Diabetes Mellitus
12%
Neuroscience
Hepatitis C
100%
Comorbidity
75%
Ledipasvir Plus Sofosbuvir
25%